Shortened treatment strategy in patients with differentiated thyroid cancer.
- Conditions
- Differentiated thyroid cancer.
- Registration Number
- NL-OMON21104
- Lead Sponsor
- MC Utrecht
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 58
Inclusion Criteria
1. Patients with proven differentiated thyroid cancer, stage T1-3N0-1M0;
2.Planned for total or completion thyroidectomy;
Exclusion Criteria
1.Pregnant or breastfeeding patients;
2.T4 (i.e. tumor expansion in vital structures) or M1 tumors;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Days of sick leave reported from time of surgery.
- Secondary Outcome Measures
Name Time Method 1. Quality of life;<br /><br>2. Costs associated with productivity at work;<br /><br>3. Societal costs associated with absence from work.